Home
Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd. Market Share Analysis for November 2025

協和キリンは、バイオテクノロジー、抗体医薬を強みとする製薬会社です。ライフサイエンスとテクノロジーの進歩を追求し、新しい価値の創造により、世界の人々の健康と豊かさに貢献します。

Health > Biotechnology and Pharmaceuticals

Domainkyowakirin.com

Year Founded2008

Employees5001 - 10000

Annual Revenue> $1B

Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd. (including company regionals)

kyowakirin.com

See more website traffic and engagement information

Kyowa Kirin Co., Ltd. Revenue up to November 2025 is > 1B

revenue generated by Kyowa Kirin Co., Ltd. top domains

Kyowa Kirin Co., Ltd. top domains revenue over 3 years

Revenue for Kyowa Kirin Co., Ltd. top domains

kyowakirin.com> 1B

See more with Sales Intelligence

Total visits to Kyowa Kirin Co., Ltd.'s top domains

Understand Kyowa Kirin Co., Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kyowakirin.com38.8K

See more with Sales Intelligence

Avg. visit duration in Kyowa Kirin Co., Ltd.'s top domains

Analyze Kyowa Kirin Co., Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kyowakirin.com00:00:46

See more with Sales Intelligence

Avg. pageviews on Kyowa Kirin Co., Ltd.'s top domains

See how Kyowa Kirin Co., Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kyowakirin.com1.90

See more with Sales Intelligence

Kyowa Kirin Co., Ltd. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

luye.cnCompany NameLuye PharmaEmployees1001 - 5000HQChina, ShanghaiAnnual revenue$500M - $1BTotal visits14.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Kyowa Kirin Co., Ltd.

These are the website technologies, by industry, used by Kyowa Kirin Co., Ltd. top domains

Advertising (8)

DoubleClick

Conversion & Analytics (3)

Google Analytics

eCommerce (3)

DHL

Audio Video Media (2)

YouTube

More Technologies

8

See all

News & Signals from Kyowa Kirin Co., Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKyowa Kirin International attends event 2025 ASH Annual Meeting.Kura Oncology and Kyowa Kirin announce presentations of ziftomenib ven/aza combination data in frontline and relapsed/refractory NPM1-m or KMT2A-r Acute Myeloid Leukemia at 2025 ASH Annual Meeting.

NewsKyowa Kirin International launched KOMET-017 trials on Sep 29th '25.Kura and Kyowa Kirin announced the launch of the KOMET-017 trials on September 29, 2025.

NewsKyowa Kirin International launches Cutaneous T-cell lymphoma Staging Tool on PROBEinCTCL.com.Kyowa Kirin is launching its Cutaneous T-cell lymphoma (CTCL) Staging Tool on PROBEinCTCL.com.